BugSeq Bioinformatics, a biotech company developing next-generation microbiology assays, has entered a public-private partnership with the U.S. Biomedical Advanced Research ...
Pre-clinical studies published today in Science Translational Medicine indicate that the SpFN vaccine protects non-human primates from disease caused by ...
Scientists at Washington University School of Medicine in St. Louis are collaborating with the NIH researchers to test the MM3122 ...
BARDA renews collaboration with OraSure Technologies to support InteliSwab™ COVID-19 Rapid Test 510(k) Clearance and CLIA Waiver BARDA and OraSure ...
Like many U.S. research and development agencies, the Department of Homeland Security (DHS) Science and Technology Directorate (S&T) was forced to shift ...
A large international consortium of almost 200 researchers from 14 leading institutions in six countries has studied three different coronaviruses ...
British cancer doctor Prof Karol Sikora recently claimed that the current COVID-19 pandemic would “burn itself out”. His thinking is ...
The neutralizing antibody, called S309, is on an accelerated path toward clinical trials An antibody first identified in a blood ...
Senator Edward J. Markey (D-Mass.) today introduced legislation to conduct or support comprehensive research for the creation of a universal ...
The current outbreak of a new coronavirus disease, named COVID-19, raises the question of where diseases like this come from ...
The drug EIDD-1931 was effective against SARS and MERS viruses in the laboratory, and a modified version (EIDD-2801) could potentially ...
The coronavirus epidemic in China has now claimed more lives than the SARS outbreak of 2002 and 2003. The number ...
Steroids should be avoided in the treatment of the current novel coronavirus, experts have advised. A commentary article published in The ...
Since December 2019, there has been a cluster of 59 cases of pneumonia in Wuhan, eastern China. The pneumonia is ...
New research published in Cell Reports from scientists at the National Institute of Allergy and Infectious Diseases (NIAID) shows how ...
The 2018 review of the World Health Organization’s Blueprint list of priority diseases occurred February 6-7, 2018. Given their potential ...
A Phase 1b multiple ascending dose study to evaluate the safety and tolerability of UV-4B has been initiated by Emergency ...
A Phase I clinical trial for Middle East Respiratory Syndrome GLS-5300 vaccine, funded and conducted by the Walter Reed Army ...
Credit: Shutterstock The California Life Sciences Association (CLSA) will host its “Afternoon with Thought Leaders” program in La Jolla, Calif. ...
When it comes to epidemics or pandemics in the context of national security, few other risks pose such a threat ...
